TLA
  • Twitter
  • GitHub
  • Home
  • TPS
  • BPLP

Insights

  • Accelerating Tech Innovation
  • TCC Hospitals
  • Tech Innovation for COVID-19

Best Practices

  • best practices blog 1

Learning Materials

  • learning blog 1
  • learning blog 2

Articles

  • TCC Strategies for Covid-19
  • Tele-ICUs for Covid-19
  • Ventilator Stockpile for Covid-19
  • Cost-Effective ICU Telemedicine
  • Business Case for Tele-ICUs
  • Efficacy of Remote Critical Care

External Blogs

  • CDC News
  • Federal Telemedicine News
  • Public Healgh Emergency / ASPR Blog
  • The Digital Responder

Recommendation to Pause Use of Johnson & Johnson's Janssen COVID-19 Vaccine

Posted April 16, 2021 by undefined

CDC recommends pausing use of the J&J/Janssen COVID-19 vaccine following a rare and severe type of blood clot in 6 people who received the vaccine. (147 characters)


Read a full article at https://tools.cdc.gov/api/embed/downloader/download.asp?m=404952&c=420600

Edit this page on GitHub

← Clinical Care Guidance for Healthcare Professionals about Coronavirus (COVID-19)
Developing Vaccines Quickly →
  • Powered by Crisis Technologies Innovation Lab at Indiana University
  • Home
  • Privacy
  • Contact